Pharsight

1. Drug name - AYVAKIT

Patent Number	Company	Patent Title	Patent Expiry
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9944651	BLUEPRINT MEDICINES	Compositions useful for treating disorders related to kit	Oct, 2034 (12 years from now)
US9994575	BLUEPRINT MEDICINES	Compositions useful for treating disorders related to kit	Oct, 2034 (12 years from now)
US9200002	BLUEPRINT MEDICINES	Compositions useful for treating disorders related to KIT	Oct, 2034 (12 years from now)
CN105658652B	BLUEPRINT MEDICINES	Compound That Can Be Used To Treat A Disorder Associated With Kit	Oct, 2034 (12 years from now)
CN105658652A	BLUEPRINT MEDICINES	Composition For Treating Kit Disorders	Oct, 2034 (12 years from now)
IN341186B	BLUEPRINT MEDICINES	Compositions Useful For Treating Disorders Related To Kit	Oct, 2034 (12 years from now)
IN201617009956A	BLUEPRINT MEDICINES	Compositions Useful For Treating Disorders Related To Kit	Oct, 2034 (12 years from now)
EP3409674B1	BLUEPRINT MEDICINES	Process For Preparing Compositions Useful For Treating Disorders Related To Kit	Oct, 2034 (12 years from now)
EP3409674A1	BLUEPRINT MEDICINES	Process For Preparing Compositions Useful For Treating Disorders Related To Kit	Oct, 2034 (12 years from now)
EP3057969B1	BLUEPRINT MEDICINES	Compositions Useful For Treating Disorders Related To Kit	Oct, 2034 (12 years from now)
EP3057969A1	BLUEPRINT MEDICINES	Compositions Useful For Treating Disorders Related To Kit	Oct, 2034 (12 years from now)

Treatment: NA

Dosage: TABLET;ORAL